Human Genetics and Genomics AdvancesGenetic & Genomic MedicinePeer-reviewed journal article
BinomiRare: A carriers-only test for association of rare genetic variants with a binary outcome for mixed models and any case-control proportion
Tamar SoferiD, Jiwon LeeiD, Nuzulul KurniansyahiD, Deepti JainiD, Cecelia A. LaurieiD, Stephanie M. GogarteniD, Matthew P. ConomosiD, Ben HeavneriD, Yao HuiD, Charles L KooperbergiD, Jeffrey HaessleriD, Ramachandran Srini VasaniD, L. Adrienne CupplesiD, Brandon J. CoombesiD, Amanda A. SeyerleiD, Sina A. GharibiD, Han CheniD, Jeffrey R. O’ConnelliD, Man ZhangiD, Daniel J. GottliebiD, Bruce M. PsatyiD, William T. Longstreth Jr.iD, Jerome I. RotteriD, Kent D. TayloriD, Stephen S. RichiD, , Elizabeth D. SchifanoiD
Abstract
Whole genome and exome sequencing studies have become increasingly available and are being used to identify rare genetic variants associated with health and disease outcomes. Investigators routinely use mixed models to account for genetic relatedness or other clustering variables (e.g. family or household) when testing genetic associations. However, no existing tests of the association of a rare variant association with a binary outcome in the presence of correlated data controls the Type 1 error where there are (1) few carriers of the rare allele, (2) a small proportion of cases relative to controls, and (3) covariates to adjust for. Here, we address all three issues in developing the carriers-only test framework for testing rare variant association with a binary trait. In this framework, we estimate outcome probabilities under the null hypothesis, and then use them, within the carriers, to test variant associations. We extend the BinomiRare test, which was previously proposed for independent observations, and develop the Conway-Maxwell-Poisson (CMP) test, and study their properties in simulations. We show that the BinomiRare test always controls the type 1 error, while the CMP test sometimes does not. We then use the BinomiRare test to test the association of rare genetic variants in target genes with small vessel disease stroke, short sleep, and venous thromboembolism, in whole-genome sequence data from the Trans-Omics for Precision Medicine program.
- organism: human
- assay: whole-genome sequencing
- research focus: variant effect prediction
- approach: statistical model
- Citations
- 5
- FWCI
- 0.57
- Field percentile
- top 38%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Rare variants association testing for a binary outcome when pooling individual level data from heterogeneous studies
Tamar Sofer, Na Guo·Genetic EpidemiologyPeer-reviewed·Oct 22, 2020
- Testing Rare-Variant Association without Calling Genotypes Allows for Systematic Differences in Sequencing between Cases and Controls
Yi-Juan Hu, Peizhou Liao, … Glen Satten·PLOS GeneticsPeer-reviewed·May 6, 2016
- COBT: A gene-based rare variant burden test for case-only study designs using aggregated genotypes from public reference cohorts.
Antoine Favier, Stefania Chounta, … Antonio Rausell·Genome MedicinePeer-reviewed·Mar 24, 2026
- Efficient and Flexible Integration of Variant Characteristics in Rare Variant Association Studies Using Integrated Nested Laplace Approximation
Hana Sušak, Laura Serra, … Stephan Ossowski·PLoS Computational BiologyPeer-reviewed·Feb 19, 2021
- Extreme sampling for genetic rare variant association analysis of dichotomous traits with focus on infectious disease susceptibility
MJ. Emond, T. Eoin West·bioRxiv·Dec 2, 2021
- Leveraging Family History in Case-Control Analyses of Rare Variation
Claudia Solís‐Lemus, S. Taylor Fischer, … Michael P. Epstein·GeneticsPeer-reviewed·Dec 16, 2019